358 related articles for article (PubMed ID: 18184173)
41. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
Holmäng S; Johansson SL
Cancer; 2004 Aug; 101(4):741-7. PubMed ID: 15305404
[TBL] [Abstract][Full Text] [Related]
42. Treatment and outcome of invasive bladder cancer in patients after renal transplantation.
Master VA; Meng MV; Grossfeld GD; Koppie TM; Hirose R; Carroll PR
J Urol; 2004 Mar; 171(3):1085-8. PubMed ID: 14767276
[TBL] [Abstract][Full Text] [Related]
43. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma.
Muntener M; Nielsen ME; Romero FR; Schaeffer EM; Allaf ME; Brito FA; Pavlovich CP; Kavoussi LR; Jarrett TW
Eur Urol; 2007 Jun; 51(6):1639-44. PubMed ID: 17240038
[TBL] [Abstract][Full Text] [Related]
44. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
45. Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results.
Rouprêt M; Harmon JD; Sanderson KM; Barret E; Cathelineau X; Vallancien G; Rozet F
BJU Int; 2007 Mar; 99(3):623-7. PubMed ID: 17407517
[TBL] [Abstract][Full Text] [Related]
46. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
[TBL] [Abstract][Full Text] [Related]
47. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
Sanderson KM; Rouprêt M
BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
[TBL] [Abstract][Full Text] [Related]
48. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
49. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
50. Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy.
Hsueh TY; Huang YH; Chiu AW; Huan SK; Lee YH
BJU Int; 2007 Mar; 99(3):632-6. PubMed ID: 17166239
[TBL] [Abstract][Full Text] [Related]
51. Incidental diagnosis of transitional cell carcinoma during percutaneous nephrolithotomy.
Inci K; Guliyev F; Bilen CY; Sahin A; Ozen H
Urol Int; 2009; 83(3):291-4. PubMed ID: 19829028
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
[TBL] [Abstract][Full Text] [Related]
53. [Subsequent upper urothelial cancer following bladder tumor].
Kuruma H; Ao T; Murayama M; Mizoguchi H; Koshiba K
Hinyokika Kiyo; 2002 Apr; 48(4):199-202. PubMed ID: 12048930
[TBL] [Abstract][Full Text] [Related]
54. Urologic de novo malignancies after kidney transplantation: a single center experience.
Karczewski M; Czapiewski W; Karczewski J
Transplant Proc; 2012 Jun; 44(5):1293-7. PubMed ID: 22664003
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
56. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
57. [What is the role of endoscopy in the diagnosis and treatment of tumors of the upper urinary tract?].
Gelet A; Ballanger P; Abbar M; Viguier JL; Marechal JM
Prog Urol; 1991 Apr; 1(2):245-60. PubMed ID: 1844826
[TBL] [Abstract][Full Text] [Related]
58. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
[TBL] [Abstract][Full Text] [Related]
59. [Influence of taking aristolochic acid-containing Chinese drugs on occurrence of urinary transitional cell cancer in uremic uremic patients undergoing dialysis].
Li WH; Yang L; Su T; Song Y; Li XM
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2487-91. PubMed ID: 16321276
[TBL] [Abstract][Full Text] [Related]
60. Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis.
Tsaur I; Karalis A; Blaheta R; Juengel E; Vallo S; Scheuermann EH; Kachel HG; Waaga-Gasser AM; Chandraker A; Obermüller N; Probst M
Am J Med Sci; 2011 Jun; 341(6):478-83. PubMed ID: 21412138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
